World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
76
Citations
24563
World Ranking
1882
National Ranking
168

Ajit Lalvani publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Ajit Lalvani sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 278 publications — 59th percentile

59% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Ajit Lalvani D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Ajit Lalvani sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 76 D-Index — 62nd percentile

62% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • Fellow of The Academy of Medical Sciences, United Kingdom
  • Fellow of The Academy of Medical Sciences, United Kingdom

Overview

Ajit Lalvani is affiliated with Imperial College London in the United Kingdom and has contributed extensively to the field of medicine, with a primary focus on infectious diseases. Their research encompasses epidemiology, molecular biology, modeling and simulation, and surgery. This body of work includes numerous studies related to tuberculosis and COVID-19.

Their research topics cover a diverse range within infectious diseases, including:

  • Tuberculosis Research and Epidemiology
  • SARS-CoV-2 and COVID-19 Research
  • Mycobacterium research and diagnosis
  • COVID-19 epidemiological studies
  • SARS-CoV-2 detection and testing
  • COVID-19 Clinical Research Studies
  • Long-Term Effects of COVID-19

Ajit Lalvani has published in several prominent scientific venues. Notable frequent publication venues include:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • The Lancet Infectious Diseases
  • The Lancet Microbe
  • Nature Communications
  • SSRN Electronic Journal

Their recent papers include:

  • Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study (2021) in The Lancet Infectious Diseases
  • Cross-reactive memory T cells associate with protection against SARS-CoV-2 infection in COVID-19 contacts (2022) in Nature Communications
  • A systematic review and meta-analysis of long term physical and mental sequelae of COVID-19 pandemic: call for research priority and action (2022) in Molecular Psychiatry
  • The 2021 WHO catalogue of Mycobacterium tuberculosis complex mutations associated with drug resistance: a genotypic analysis (2022) in The Lancet Microbe
  • Prevalence and risk factor for long COVID in children and adolescents: A meta-analysis and systematic review (2023) in Journal of Infection and Public Health

Frequent collaborators in Ajit Lalvani's research include:

  • Kieran Madon
  • Seran Hakki
  • Emily Conibear
  • Joe Fenn
  • Timesh D Pillay

Ajit Lalvani has been recognized as a Fellow of The Academy of Medical Sciences in the United Kingdom. This affiliation reflects a professional standing within the academic medical sciences community.

Best Publications

  • Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in west London: a case-control study

    Robert J Wilkinson;Robert J Wilkinson;Martin Llewelyn;Zahra Toossi;Punita Patel

  • Cellular immune correlates of protection against symptomatic pandemic influenza

    Saranya Sridhar;Shaima Begom;Alison Bermingham;Katja Hoschler

  • Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak

    Katie Ewer;Jonathan Deeks;Lydia Alvarez;Gerry Bryant

  • Rapid Effector Function in CD8+ Memory T Cells

    Ajit Lalvani;Roger Brookes;Sophie Hambleton;Warwick J. Britton

  • A systematic review of rapid diagnostic tests for the detection of tuberculosis infection.

    J Dinnes;J Deeks;H Kunst;A Gibson

  • Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study.

    Anika Singanayagam;Anika Singanayagam;Anika Singanayagam;Seran Hakki;Jake Dunning;Jake Dunning;Kieran J Madon

  • Rapid detection of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells.

    Ajit Lalvani;Ansar A. Pathan;Helen McSHANE;Robert J. Wilkinson

  • Effect of BCG vaccination against Mycobacterium tuberculosis infection in children: systematic review and meta-analysis

    A Roy;M Eisenhut;R J Harris;L C Rodrigues

  • Regulatory T cells are expanded in blood and disease sites in patients with tuberculosis.

    Valerie Guyot-Revol;John A. Innes;Sarah Hackforth;Tim Hinks

  • Enhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells

    Ajit Lalvani;Ansar A. Pathan;Helen Durkan;Katalin A. Wilkinson

  • Diagnosis of tuberculosis in South African children with a T-cell-based assay: a prospective cohort study.

    Susan Liebeschuetz;Sheila Bamber;Katie Ewer;Jonathan Deeks

  • Direct ex vivo analysis of antigen-specific IFN-gamma-secreting CD4 T cells in Mycobacterium tuberculosis-infected individuals: associations with clinical disease state and effect of treatment.

    Ansar A. Pathan;Katalin A. Wilkinson;Paul Klenerman;Helen McShane

  • Human cytolytic and interferon gamma-secreting CD8+ T lymphocytes specific for Mycobacterium tuberculosis.

    Ajit Lalvani;Roger Brookes;Robert J. Wilkinson;Adam S. Malin

  • Diagnosing tuberculosis infection in the 21st century: new tools to tackle an old enemy.

    Ajit Lalvani

  • Rapid detection of active and latent tuberculosis infection in HIV-positive individuals by enumeration of Mycobacterium tuberculosis-specific T cells.

    Ann L. N. Chapman;Mwansa Munkanta;Katalin A. Wilkinson;Ansar A. Pathan

  • Cross-reactive memory T cells associate with protection against SARS-CoV-2 infection in COVID-19 contacts

    Unknown

  • Enumeration of T Cells Specific for RD1-Encoded Antigens Suggests a High Prevalence of Latent Mycobacterium tuberculosis Infection in Healthy Urban Indians

    Ajit Lalvani;Punam Nagvenkar;Zarir Udwadia;Ansar A. Pathan

  • Effect of BCG vaccination on risk of Mycobacterium tuberculosis infection in children with household tuberculosis contact: a prospective community-based study

    Ahmet Soysal;Kerry A Millington;Mustafa Bakir;Davinder Dosanjh

  • Dynamic relationship between IFN-gamma and IL-2 profile of Mycobacterium tuberculosis-specific T cells and antigen load.

    Kerry A. Millington;John A. Innes;Sarah Hackforth;Timothy S. C. Hinks

  • Phase I/IIa Safety, Immunogenicity, and Efficacy Trial of NYVAC-Pf7, a Pox-Vectored, Multiantigen, Multistage Vaccine Candidate for Plasmodium falciparum Malaria

    Christian F. Ockenhouse;Pei Fang Sun;David E. Lanar;Bruce T. Wellde

  • Dynamic antigen-specific T-cell responses after point-source exposure to Mycobacterium tuberculosis.

    Katie Ewer;Kerry A. Millington;Jonathan J. Deeks;Lydia Alvarez

Frequent Co-Authors

Jonathan J Deeks
Jonathan J Deeks University of Birmingham
Katie J. Ewer
Katie J. Ewer University of Oxford
Ibrahim Abubakar
Ibrahim Abubakar University College London
Adrian V. S. Hill
Adrian V. S. Hill University of Oxford
Luca Richeldi
Luca Richeldi Catholic University of the Sacred Heart
Robert J. Wilkinson
Robert J. Wilkinson The Francis Crick Institute
Francis Drobniewski
Francis Drobniewski Imperial College London
Katalin A. Wilkinson
Katalin A. Wilkinson The Francis Crick Institute
Marc Lipman
Marc Lipman Royal Free London NHS Foundation Trust
Leonardo M. Fabbri
Leonardo M. Fabbri University of Ferrara

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to diverse career paths in healthcare and research. Many professionals complement their immunology background with nursing qualifications to enhance patient care skills. For those looking to quickly advance in nursing, accelerated nurse practitioner programs offer a fast track to becoming advanced practice nurses with specialized knowledge.

Non-nurses interested in entering the field can explore foundational options like online ADN programs for non nurses, which provide essential nursing education accessible from anywhere. For those aiming to earn a Bachelor of Science in Nursing quickly, absn programs with high acceptance rates present practical opportunities with less competitive admissions.

Additionally, if you are looking to enter nursing with a shorter commitment, understanding which LPN programs are easiest to get into can help you start your nursing career sooner. These pathways not only support career growth but also expand the impact immunology knowledge can have in patient health and treatment innovations.

Best Scientists Citing Ajit Lalvani

Trending Scientists

Recently Published Articles